Skip to main content

Want a detailed portfolio tracker?

Ascendis Pharma A/S (ASND) P/E (2015 - 2026)

Ascendis Pharma A/S (ASND) P/E from Jan 28, 2015 to Jun 3, 2026. The TTM Ascendis Pharma A/S (ASND) P/E is 24.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ascendis Pharma A/S (ASND)

YearP/EChange
202624.28-148.19%
2025-50.39+158.97%
2024-19.46+77.22%
2023-10.98-17.47%
2022-13.30-18.21%
2021-16.27-7.04%
2020-17.50-34.00%
2019-26.51+58.09%
2018-16.77+53.08%
2017-10.96+54.10%
2016-7.11-42.31%
2015-12.32N/A

Comparison Ascendis Pharma A/S (ASND) P/E with competitors

Ascendis Pharma A/S (ASND) P/E is 24.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.10-99.58%
ENLVEnlivex Therapeutics Ltd0.15-99.38%
FGENFibroGen Inc0.24-99.01%
TRAWTraws Pharma Inc0.47-98.05%
FBIOFortress Biotech Inc0.71-97.09%
CHRSCoherus Biosciences Inc0.98-95.97%
ORMPOramed Pharmaceuticals Inc1.47-93.93%
AGENAgenus Inc2.05-91.57%
VIVSVivoSim Labs Inc2.54-89.56%
INVAInnoviva Inc3.19-86.87%
CRMDCorMedix Inc3.65-84.99%
ABEOAbeona Therapeutics Inc4.20-82.69%
VXRTVaxart Inc4.26-82.45%
CVACCureVac N.V.4.45-81.69%
SRPTSarepta Therapeutics Inc4.62-80.96%
GLPGGalapagos NV4.86-79.99%
RIGLRigel Pharmaceuticals4.92-79.74%
ZVRAZevra Therapeutics Inc4.97-79.52%
ABUSArbutus Biopharma Corp5.69-76.55%
CGENCompugen Ltd7.38-69.59%
AUPHAurinia Pharmaceuticals Inc9.25-61.90%
ACADAcadia Pharmaceuticals Inc9.59-60.52%
OMEROmeros Corporation9.88-59.30%
PLXProtalix BioTherapeutics Inc9.91-59.20%
SPROSpero Therapeutics Inc10.73-55.80%
ADMAAdma Biologics Inc11.33-53.34%
SVASinovac Biotech Ltd11.44-52.91%
TBPHTheravance Biopharma Inc11.78-51.51%
HRMYHarmony Biosciences Holdings Inc12.18-49.84%
TGTXTG Therapeutics Inc13.18-45.73%
INCYIncyte Corp13.38-44.90%
SABSSAB Biotherapeutics Inc14.06-42.11%
XOMAXOMA Corp14.95-38.46%
REGNRegeneron Pharmaceuticals Inc14.98-38.31%
PBYIPuma Biotechnology Inc15.05-38.03%
EXELExelixis Inc15.79-34.96%
NAGENiagen Bioscience Inc16.35-32.65%
CPRXCatalyst Pharmaceuticals Inc17.34-28.58%
MDXGMimedx Group Inc17.38-28.45%
ARGXArgen X SE23.07-5.00%
HALOHalozyme Therapeutics Inc23.20-4.47%
XOMAOXOMA Corp25.34+4.36%
VRTXVertex Pharmaceuticals Inc25.66+5.65%
XOMAPXOMA Corp25.67+5.70%
CTMXCytomX Therapeutics Inc25.70+5.82%
RPRXRoyalty Pharma plc - Class A27.50+13.22%
SLNOSoleno Therapeutics Inc29.02+19.48%
LGNDLigand Pharmaceuticals Inc - Class B30.19+24.30%
BMRNBiomarin Pharmaceutical Inc37.51+54.45%
APLSApellis Pharmaceuticals Inc39.02+60.68%
KRYSKrystal Biotech Inc39.70+63.47%
GMABGenmab40.20+65.55%
ONCBeiGene Ltd67.03+176.00%
TECHBio-Techne Corp68.59+182.46%
VCELVericel Corp80.63+232.01%
PHARPharming Group N.V.87.74+261.30%
ALNYAlnylam Pharmaceuticals Inc124.93+414.45%
TLXTelix Pharmaceuticals Ltd139.89+476.04%
CORTCorcept Therapeutics Inc158.39+552.21%